Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 126 - 150 of 165 in total

GDC-0623

GDC-0623 has been used in trials studying the treatment of Solid Cancers.
Investigational

Iniparib

Investigational

5-iodotubercidin

Experimental

2-HYDROXY-3,5-DIIODOBENZOIC ACID

Experimental

Iofolastat I-123

Iofolastat I-123 is under investigation in clinical trial NCT00992745 (A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer).
Investigational

3-Iodo-Tyrosine

Experimental

5-Bromo-N-[(2S)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

Experimental

2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide

Experimental

4-Iodo-D-phenylalanine

Experimental

(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide

Experimental

Refametinib

Investigational

Iodamide

Iodamide is a contrast medium molecule that is no longer marketed in the United States.
Withdrawn

Chiniofon

Experimental

N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE

Experimental

Iopentol

Iopentol is used as a contrast medium.
Experimental

Ioforminol

Ioforminol has been used in trials studying the diagnostic of Cardio Renal Safety in High-risk Elderly Subjects Undergoing a Coronary CATH With or Without PCI.
Investigational

Piclidenoson

CF 101 (known generically as IB-MECA) is an anti-inflammatory drug for rheumatoid arthritis patients. Its novel mechanism of action relies on antagonism of adenoside A3 receptors. CF101 is supplied as an oral drug and has an excellent safety profile. It is also being considered for the treatment of other autoimmune-inflammatory...
Investigational

1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID

Experimental

Iotroxic acid

Iotroxic acid is a contrast medium molecule.
Experimental
Withdrawn

Iobenzamic acid

Experimental

4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION

Experimental

Altropane

Boston Life Sciences (BLS) is developing Altropane as a potential radio-imaging agent to be used with single photon emission tomography (SPECT), for the early diagnosis of Parkinson's disease (PD) and attention deficit hyperactivity disorder (ADHD).
Investigational

Mirdametinib

PD-0325901 has been used in trials studying the treatment and basic science of Melanoma, Solid Tumour, Solid Tumors, Advanced Cancer, and Breast Neoplasms, among others.
Investigational

Acetrizoic acid

Acetrizoic acid presents the molecular formula of 3-acetamidol-2,4,6-triiodobenzoic acid and it is the first monomeric ionic compound used as an X-ray contrast agent. It was first synthesized by Wallingford in 1953 and it was filled in the FDA by the Johnson & Johnson subsidiary, Cilag Chemie AG, on February 8th,...
Withdrawn

N-Alpha-Acetyl-3,5-Diiodotyrosylglycine

Experimental
Displaying drugs 126 - 150 of 165 in total